JENNIFER SIMS: Open Payments
NPI 1730720723 · ARDMORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 33 payments from 12 companies in 2025. Trend: 2023 $569 · 2024 $800 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 8 | $133 |
| Fresenius USA Marketing, Inc. | 5 | $94 |
| Calliditas Therapeutics US Inc. | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| ANI Pharmaceuticals, Inc. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Ardelyx, Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Novo Nordisk Inc | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: VELPHORO, TARPEYO, FARXIGA, PURIFIED CORTROPHIN GEL, Kerendia, IBSRELA, JARDIANCE, Ozempic.
Industry payments across OK — which companies pay providers there.
